Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Consumption of Dairy Product on Upper Gastric Discomfort

This study has been completed.
Information provided by (Responsible Party):
Danone Research Identifier:
First received: April 21, 2011
Last updated: October 7, 2016
Last verified: October 2016
The purpose of this study is to determine whether the consumption of test dairy products is effective in reducing upper gastric discomfort after 2 weeks of product consumption.

Condition Intervention
Upper Gastric Discomfort
Other: 1- Test dairy product containing specific ingredients
Other: 2- Control dairy product without specific ingredients

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Official Title: Effect of Consumption of Dairy Product on Upper Gastric Discomfort

Further study details as provided by Danone Research:

Primary Outcome Measures:
  • Change in gastro-oesophageal symptoms as assessed by RDQ questionnaire [ Time Frame: Two timepoints are considered in the assessment of the change outcome measures: from Baseline (before product consumption) to Endpoint (i.e. final evaluation visit after 2 weeks of product consumption) ] [ Designated as safety issue: No ]

Enrollment: 236
Study Start Date: November 2010
Study Completion Date: July 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 = Test product
Arm 1 - intervention 1 (test product)
Other: 1- Test dairy product containing specific ingredients
Placebo Comparator: 2 = Control product
Arm 2 - intervention 2 (control product)
Other: 2- Control dairy product without specific ingredients


Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male and female
  • 21 - 60 years old
  • Experiencing upper gastric discomfort

Exclusion Criteria:

  • Participants with alarm symptoms (dysphagia, bleeding, involuntary weight loss clinically significant >10% of it habitual weight during the last 6 months).
  • Participants with diagnosed severe organic esophageal medical history (endoscopic eosophagitis A, B, C or D of Los Angeles classification, peptic stenosis, Barrett oesophagus, huge hiatus hernia or para-esophageal) gastric or duodenal ulcer or high digestive haemorrhage clinical history.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01422980

Hospital Italiano
BuenosAires, Argentina, 1116
Sponsors and Collaborators
Danone Research
  More Information

Responsible Party: Danone Research Identifier: NCT01422980     History of Changes
Other Study ID Numbers: NU345 
Study First Received: April 21, 2011
Last Updated: October 7, 2016
Health Authority: Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica

Keywords provided by Danone Research:
dairy product
upper gastric discomfort
adult processed this record on October 25, 2016